Download

Full Text

• Gomez, C.; Hallot, G.; Port, M. Bismuth Metallic Nanoparticles. In Inorganic Framework as Smart Nanomedicines; William Andrew: Norwich, NY, USA, 2018; pp. 1–699.
• Shahbazi, M.A.; Faghfouri, L.; Ferreira, M.P.A.; Figueiredo, P.; Maleki, H.; Sefat, F.; Hirvonen, J.; Santos, H.A. The versatile biomedical applications of bismuth-based nanoparticles and composites: Therapeutic, diagnostic, biosensing, and regenerative properties. Chem. Soc. Rev. 2020, 49, 1253–1321. [CrossRef]
• Wang, F.; Tang, R.; Yu, H.; Gibbons, P.C.; Buhro, W.E. Size-and Shape-Controlled Synthesis of Bismuth Nanoparticles. Chem. Mater. 2008, 20, 3656–3662. [CrossRef]
• Xia, F.; Xu, X.; Li, X.; Zhang, L.; Zhang, L.; Qiu, H.; Wang, W.; Liu, Y.; Gao, J. Preparation of Bismuth Nanoparticles in Aqueous Solution and Its Catalytic Performance for the Reduction of 4-Nitrophenol. Ind. Eng. Chem. Res. 2014, 53, 10576–10582. [CrossRef]
• Pothula, K.; Tang, L.; Zha, Z.; Wang, Z. Bismuth Nanoparticles: An Efficient Catalyst for Reductive Coupling of Nitroarenes to Azo-Compounds. RSC Adv. 2015, 5, 83144–83148. [CrossRef]
• Thanh, N.T.K.; Maclean, N.; Mahiddine, S. Mechanisms of Nucleation and Growth of Nanoparticles in Solution. Chem. Rev. 2014, 114, 7610–7630. [CrossRef] [PubMed]
• Cui, Z.; Zhang, Y.; Li, S.; Ge, S. Preparation and Photocatalytic Performance of Bi Nanoparticles by Microwave-Assisted Method Using Ascorbic Acid as Reducing Agent. Catal. Commun. 2015, 72, 97–100. [CrossRef]
• Lusic, H.; Grinsta, M.W. X-ray-Computed Tomography Contrast Agents. Chem. Rev. 2013, 113, 1641–1666. [CrossRef]
• Lee, N.; Choi, S.H.; Hyeon, T. Nano-Sized CT Contrast Agents. Adv. Mater. 2013, 25, 2641–2660. [CrossRef] [PubMed]
• Liu, Y.; Ai, K.; Lu, L. Nanoparticule X-Ray Computed Tomography Contrast Agents: From Design Validation to in Vivo Applications. Acc. Chem. Res. 2012, 45, 1817–1827. [CrossRef]
• Shilo, M.; Reuveni, T.; Motiei, M.; Popovtezer, R. Nanoparticles as Computed Tomography Contrast Agents: Current Status and Future Perspectives R Eview. Nanomedecine 2012, 7, 257–269. [CrossRef]
• Yang, X.; Yang, M.; Pang, B.; Vara, M.; Xia, Y.; States, U. Gold Nanomaterials at Work in Biomedicine. Chem. Rev. 2015, 115, 10410–10488. [CrossRef] [PubMed]
• Brown, A.L.; Naha, P.C.; Benavides-Montes, V.; Litt, H.I.; Goforth, A.M.; Cormode, D.P. Synthesis, X-Ray Opacity, and Biological Compatibility of Ultra-High Payload Elemental Bismuth Nanoparticle X-Ray Contrast Agents. Chem. Mater. 2014, 26, 2266–2274. [CrossRef]
• Wei, B.; Zhang, X.; Zhang, C.; Jiang, Y.; Fu, Y.Y.; Yu, C.; Sun, S.K.; Yan, X.P. Facile Synthesis of Uniform-Sized Bismuth Nanoparticles for CT Visualization of Gastrointestinal Tract in Vivo. ACS Appl. Mater. Interfaces 2016, 8, 12720–12726. [CrossRef]
• Chakravarty, S.; Unold, J.; Shuboni-mulligan, D.D.; Blanco-fernandez, B.; Shapiro, E.M. Surface Engineering of Bismuth Nanocrystals to Counter Dissolution. Nanoscale 2016, 8, 13217–13222. [CrossRef] [PubMed]
• Swy, E.R.; Schwartz-Duval, A.S.; Shuboni, D.D.; Latourette, M.T.; Mallet, C.L.; Parys, M.; Cormode, D.P.; Shapiro, E.M. Dual-Modality, Fluorescent, PLGA Encapsulated Bismuth Nanoparticles for Molecular and Cellular Fluorescence Imaging and Computed Tomography. Nanoscale 2014, 6, 13104–13112. [CrossRef]
• Liu, Y.; Zhuang, J.; Zhang, X.; Yue, C.; Zhu, N.; Yang, L.; Wang, Y.; Chen, T.; Wang, Y.; Zhang, L.W. Autophagy associated cytotoxicity and cellular uptake mechanisms of bismuth nanoparticles in human kidney cells. Toxicol. Lett. 2017, 275, 39–48. [CrossRef] [PubMed]
• Bi, H.; He, F.; Dong, Y.; Yang, D.; Dai, Y.; Xu, L.; Lv, R.; Gai, S.; Yang, P.; Lin, J. Bismuth Nanoparticles with “ Light ” Property Served as Multi-Functional Probe for X-ray Computed Tomography and Fluorescence Imaging. Chem. Mater. 2018, 30, 3301–3307. [CrossRef]
• Torrisia, L.; Silipignia, L.; Restucciaa, N.; Cuzzocreab, S.; Cutroneoc, M.; Barrecaa, F.; Faziod, B.; Di Marcod, G.; Guglielminoe, S. Laser-generated bismuth nanoparticles for applications in imaging and radiotherapy. J. Phys. Chem. Solids 2018, 119, 62–70. [CrossRef]
• Li, Z.; Liu, J.; Hu, Y.; Li, Z.; Fan, X.; Sun, Y.; Besenbacher, F.; Chen, C.; Yu, M. Biocompatible PEGylated Bismuth Nanocrystals: “All-in-One” Theranostic Agent with Triple-Modal Imaging and Efficient in Vivo Photothermal Ablation of Tumors. Biomaterials 2017, 141, 284–295. [CrossRef] [PubMed]
• Yu, X.; Li, A.; Zhao, C.; Yang, K.; Chen, X.; Li, W. Ultrasmall Semimetal Nanoparticles of Bismuth for Dual Modal Computed Tomography/Photoacoustic Imaging and Synergistic Thermoradiotherapy. ACS Nano 2017, 11, 3990–4001. [CrossRef]
• Yang, S.; Li, Z.; Wang, Y.; Fan, X.; Miao, Z.; Hu, Y.; Li, Z.; Sun, Y.; Besenbacher, F.; Yu, M. Multifunctional Bi @ PPy-PEG Core—Shell Nanohybrids for Dual-Modal Imaging and Photothermal Therapy. ACS Appl. Mater. Interfaces 2018, 10, 1605–1615. [CrossRef]
• Yang, C.; Guo, C.; Guo, W.; Zhao, X.; Liu, S.; Han, X. Multifunctional Bismuth Nanoparticles as Theranostic Agent for PA/CT Imaging and NIR Laser-Driven Photothermal Therapy. ACS Appl. Mater. Interfaces 2018, 1, 820–830. [CrossRef]
• Liu, Y.; Zhang, P.; Li, F.; Jin, X.; Li, J.; Chen, W.; Li, Q. Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells. Theranostics 2018, 8, 1824–1849. [CrossRef] [PubMed]
• Hossain, M.; Su, M. Nanoparticle Location and Material Dependent Dose Enhancement in X-Ray Radiation Therapy. J. Phys. Chem. C Nanomater. Interfaces 2012, 116, 23047–23052. [CrossRef] [PubMed]
• Hossain, M.; Luo, Y.; Sun, Z.; Wang, C.; Zhang, M.; Fu, H.; Qiao, Y.; Su, M. Biosensors and Bioelectronics X-Ray Enabled Detection and Eradication of Circulating Tumor Cells with Nanoparticles. Biosens. Bioelectron. 2012, 38, 348–354. [CrossRef]
• Deng, J.; Xu, S.; Hu, W.; Xun, X.; Zheng, L.; Su, M. Tumor Targeted, Stealthy and Degradable Bismuth Nanoparticles for Enhanced X-Ray Radiation Therapy of Breast Cancer. Biomaterials 2018, 154, 24–33. [CrossRef]
• Jiao, L.; Li, Q.Q.; Deng, J.; Okosi, N.; Xia, J.; Su, M. Nanocellulose Templated Growth of Ultra-Small Bismuth Nanoparticles for Enhanced Radiation Therapy. Nanoscale 2018, 10, 6751–6757. [CrossRef] [PubMed]
• Yu, N.; Wang, Z.; Zhang, J.; Liu, Z.; Zhu, B.; Yu, J.; Zhu, M.; Peng, C.; Chen, Z. Thiol-Capped Bi Nanoparticles as Stable and All-in-One Type Theranostic Nanoagents for Tumor Imaging and Thermoradiotherapy. Biomaterials 2018, 161, 279–291. [CrossRef]
• Luo, Y.; Hossain, M.; Wang, C.; Qiao, Y.; An, J.J.; Ma, L.; Su, M. Targeted Nanoparticles for Enhanced X-ray Radiation Killing of Multidrug-Resistant Bacteria. Nanoscale 2013, 5, 687–694. [CrossRef] [PubMed]
• Lei, P.; An, R.; Zhang, P.; Yao, S.; Song, S.; Dong, L.; Xu, X.; Du, K.; Feng, J. Ultrafast Synthesis of Ultrasmall Poly (Vinylpyrrolidone)—Protected Bismuth Nanodots as a Multifunctional Theranostic Agent for In Vivo Dual-Modal CT/Photothermal-Imaging-Guided Photothermal Therapy. Adv. Funct. Mater. 2017, 27, 1–10. [CrossRef]
• Lu, S.; Xu, D.; Liao, R.; Luo, J.; Liu, Y.; Qi, Z.; Zhang, C.; Ye, N.; Wu, B.; Xu, H. Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy. Comput. Struct. Biotechnol. J. 2019, 17, 619–627. [CrossRef]
• Liu, C.; Zhang, L.; Chen, X.; Li, S.; Han, Q.; Li, L.; Wang, C. Biomolecules-assisted synthesis of degradable bismuth nanoparticles for dual-modal imaging-guided chemo-photothermal therapy. Chem. Eng. J. 2020, 382, 122720. [CrossRef]
• Zhao, H.; Wang, J.; Li, X.; Li, Y.; Li, C.; Wang, X.; Wang, J.; Guan, S.; Xu, Y.; Deng, G.; et al. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours. J. Colloid Interface Sci. 2021, 604, 80–90. [CrossRef]
• Hernandez-Delgadillo, R.; Velasco-Arias, D.; Diaz, D.; Arevalo-Niño, K.; Garza-Enriquez, M.; De la Garza-Ramos, M.A.; Cabral-Romero, C. Zerovalent Bismuth Nanoparticles Inhibit Streptococcus Mutans Growth and Formation of Biofilm. Int. J. Nanomed. 2012, 7, 2109–2113. [CrossRef]
• Nazari, P.; Dowlatabadi-Bazaz, R.; Mofid, M.R.; Pourmand, M.R.; Daryani, N.E.; Faramarzi, M.A.; Sepehrizadeh, Z.; Shahverdi, A.R. The Antimicrobial Effects and Metabolomic Footprinting of Carboxyl-Capped Bismuth Nanoparticles against Helicobacter Pylori. Biotechnol. Appl. Biochem. 2014, 172, 570–579. [CrossRef]
• Flores-Castaneda, M.; Vega-Jimenez, A.L.; Berea, S.E.; Camps, E.; Pe, M.; Rodil, S.E. Antibacterial Effect of Bismuth Subsalicylate Nanoparticles Synthesized by Laser Ablation. J. Nanoparticle Res. 2015, 17, 431. [CrossRef]
• Vega-Jimenez, A.L.; Almaguer-Flores, A.; Flores-Castaneda, M.; Camps, E.; Uribe-Ramirez, M.; Aztatzi-Aguilar, O.G.; De Vizcaya-Ruiz, A. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications. Nanotech-nology 2017, 28, 435101. [CrossRef] [PubMed]
• Vasquez-Munoz, R.; Arellano-Jimenez, M.J.; Lopez-Ribot, J.L. Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans. BMC Biomed. Eng. 2020, 2, 11. [CrossRef] [PubMed]
• Badireddy, A.R.; Rene, B.; Sa, R.I.; Cabral-Romero, C. Synthesis and Characterization of Lipophilic Bismuth Dimercaptopropanol Nanoparticles and Their Effects on Oral Microorganisms Growth and Biofilm Formation. J. Nanopart. Res. 2014, 16, 2456. [CrossRef]
• Badireddy, A.R.; Chellam, S.; Marinakos, S.M.; Wiesner, M.R. Lipophilic Nano-Bismuth Inhibits Bacterial Growth, Attachment, and Biofilm Formation. Surf. Innov. 2013, 1, 181–189. [CrossRef]
• Rodríguez-Luis, O.E.; Hernández-delgadillo, R.; Pineda-aguilar, N.; Vargas-villarreal, J.; González-salazar, F.; Garza-gonzález, J.N.; Hernández-garcía, M.E.; Chellam, S.; Cabral-romero, C.; De Odontología, F.; et al. Effect of Bismuth Lipophilic Nanoparticles (BisBAL NPs) on Trichomonas Vaginalis Growth. J. Nanosci. Nanotechnol. 2017, 17, 4618–4622. [CrossRef]
• Azad, A.; Rostamifar, S.; Modaresi, F.; Bazrafkan, A.; Rezaie, Z. Assessment of the Antibacterial Effects of Bismuth Nanoparticles against Enterococcus faecalis. Biomed. Res. Int. 2020, 2020, 5465439. [CrossRef]
• Rostamifar, S.; Azad, A.; Bazrafkan, A.; Modaresi, F.; Atashpour, S.; Jahromi, Z.K. New Strategy of Reducing Biofilm Forming Bacteria in Oral Cavity by Bismuth Nanoparticles. Biomed. Res. Int. 2021, 2021, 6695692. [CrossRef]
• Hernandez-Delgadillo, R.; Del Angel-Mosqueda, C.; Solís-Soto, J.M.; Munguia-Moreno, S.; Pineda-Aguilar, N.; Sánchez-Nájera, R.I. Antimicrobial and Antibiofilm Activities of MTA Supplemented with Bismuth Lipophilic Nanoparticles. Dent. Mater. J. 2017, 36, 503–510. [CrossRef] [PubMed]
• Rieznichenko, L.S.; Gruzina, T.G.; Dybkova, S.M.; Ushkalov, V.O.; Ulberg, Z.R. Investigation of Bismuth Nanoparticles Antimicro-bial Activity against High Pathogen Microorganisms. Am. J. Bioterror. Biosecur. Biodefens. 2015, 2, 1004–1008.
• Luo, Y.; Wang, C.; Qiao, Y.; Hossain, M.; Ma, L.; Su, M. In vitro cytotoxicity of surface modified bismuth nanoparticles. J. Mater Sci. Mater. Med. 2012, 23, 2563–2573. [CrossRef] [PubMed]
• Hamood, S.A.; Aldahan, Z.T. Bismuth (0) Nanoparticle as Anti-Breast Cancer Agent Synthesis and Investigation. Res. J. Pharm. Biol. Chem. Sci. 2016, 7, 809–816.
• Brown-Delgadillo, R.; Badireddy, A.R.; Zaragoza-Magaña, V.; Sánchez-nájera, R.I.; Chellam, S.; Cabral-romero, C. Effect of Lipophilic Bismuth Nanoparticles on Erythrocytes. J. Nanomater. 2015, 2015, 1–9. [CrossRef]
• Hernandez-Delgadillo, R.; Appala Raju, B.; Martinez-Sanmiguel, J.J.; Contreras-Cordero, J.F.; Martinez-Gonzalez, G.I.; Sanchez-Najera, R.I.; Shankaraman, C.; Cabral-Romero, C. Cytotoxic Effect of Lipophilic Bismuth Dimercaptopropanol Nanoparticles on Epithelial Cells. J. Nanosci. Nanotechnol. 2016, 16, 203–209. [CrossRef]
• Cabral-Romero, C.; Solis-Soto, J.M.; Sanchez-Perrez, Y.; Pineda-Aguilar, N.; Meester, I.; Perez-Carillo, E.; Nakagoshi-Cepeda, S.E.; Sanchez-Najera, R.I.; Nakagoshi-Cepeda, M.A.A.; Hernandez-Delgadillo, R.; et al. Antitumor Activity of a Hydrogel loaded with Lipophilic Bismuth Nanoparticles on Cervical, Prostate, and Colon Human Cancer Cells. Anti-Cancer Drugs 2020, 31, 251–259. [CrossRef]
• Hernandez-Delgadillo, R.; Garcia-Cuellar, C.M.; Sanchez-Perrez, Y.; Pineda-Aguilar, N.; Martinez-Martinez, M.A.; Rangel-Padilla, E.E.; Nakagoshi-Cepeda, S.E.; Solis-Soto, J.M.; Sanchez-Najera, R.I.; Nakagoshi-Cepeda, M.A.A.; et al. In vitro Evaluation of the Antitumor Effects of Bismuth Lipophilic Nanoparticles (BisBAL NPs) on Breast Cancer Cells. Inter. J. Nanomed. 2018, 13, 6089–6097. [CrossRef] [PubMed]
• Shakibaie, M.; Forootanfar, H.; Ameri, A.; Adeli-Sardou, M.; Jafari, M.; Rahimi, H.R. Cytotoxicity of Biologically Synthesised Bismuth Nanoparticles against HT-29 Cell Line. Inst. Eng. Technol. 2018, 12, 653–657. [CrossRef]
• Shakibaie, M.; Amiri-Moghadam, P.; Ghazanfari, M.; Adeli-Sardou, M.; Jafari, M.; Forootanfar, H. Cytotoxic and antioxidant activity of the biogenic bismuth nanoparticles produced by Delftia sp. SFG. Mater. Res. Bull. 2018, 104, 155–163. [CrossRef]
• Da Luz, J.Z.; Machado, T.N.; Bezerra, A.G.; Oliveira Ribeiro, C.A.; Neto, F.F. Cytotoxicity of Bismuth Nanoparticles in the Murine Macrophage Cell Line RAW 264.7. J. Mater. Sci. Mater. Med. 2020, 31, 95. [CrossRef] [PubMed]
• Reus, T.L.; Machado, T.N.; Bezerra, A.G., Jr.; Hilzendeger Marcon, B.; Campos Paschoal, A.C.; Kuligovski, C.; de Aguiar, A.M.; Dallagiovanna, B. Dose-dependent cytotoxicity of bismuth nanoparticles produced by LASiS in a reference mammalian cell line BALB/c 3T3. Toxicol. Vitro 2018, 53, 99–106. [CrossRef] [PubMed]
• Liu, Y.; Yu, H.; Zhang, X.; Wang, Y.; Song, Z.; Zhao, J.; Shi, H.; Li, R.; Wang, Y.; Zhang, L.W. The protective role of autophagy in nephrotoxicity induced by bismuth nanoparticles through AMPK/mTOR pathway. Nanotoxicology 2018, 12, 586–601. [CrossRef]